MARKETS / NASDAQ / POCI
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

Precision Optics Corporation, Inc. POCI

15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$19.1M
▼ 0.1% vs FY2023
EPS · FY24
$-0.85
Dividend / sh · FY24
Payout · FY24
ROE · FY24
-51.8%
Net margin · FY24
-30.3%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 19.1M
Revenue, FY2024 · full 15-year series below
Revenue Net income
0.0080.0160.0240.0-0.0201020132016201920222024
0.0080.0160.0240.0-0.02015201820212024

The company lost 30 cents on every revenue dollar this year.

Per share
USD -0.85
Diluted EPS, FY2024
EPS
0.40.81.2-0.85201020132016201920222024
0.40.81.2-0.852015201820212024

The company pays no cash dividend.

Profitability
-51.8%
Return on equity, FY2024
ROE
0.250.50.751-51.8%201020132016201920222024
0.250.50.751-51.8%2015201820212024
Operating margin-29.1%
Net margin-30.3%
Return on assets-31.5%

Each USD of equity lost 52 cents this year.

Returned to shareholders
returned in FY2024 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+14.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+6.8%
+14.0%
+17.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2024
0.000.01201020132016201920222024
0.010.012015201820212024
Change, 5 years+76.2%
Change, 10 years

The share count grew 76% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 19.8M
total assets, end of FY2024
Total assetsUSD 19.8M
EquityUSD 12.3M
CashUSD 1.8M
Gross debtUSD 1.9M
Net debtUSD 93,368.00
Current ratio1.64×

Net debt stands at 1% of equity.

History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
EPS, diluted $
−0.85
−0.49
−0.03
−0.18
−0.01
−0.11
−0.05
−0.04
−0.12
−0.15
−0.19
−0.26
−0.51
0.78
−1.06
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−51.8
−26.7
−1.4
−15.0
−3.3
−46.4
−31.2
−62.6
−175.7
−165.0
−167.5
−94.7
−160.4
·
·
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
60 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed